Chemours Co (CC) Financial Statements
Industry: Chemicals & Allied Products
In fiscal 2025, Chemours reported revenue of $5.81B, up 0.4% from $5.78B the year before. Net income was -$386.0M (a -6.6% net margin), or -$2.57 per diluted share. Gross margin was 15.5% and operating margin was -1.1%. Operating activities generated $264.0M of cash, leaving $51.0M of free cash flow. At fiscal year end, Chemours held $7.38B in total assets against $7.13B in total liabilities, including $670.0M of cash and equivalents.
Open the full interactive Chemours financials → Quarterly statements, key ratios, valuation history and price charts.
Chemours Key Stats
| Share Price | $13.20 |
|---|---|
| Market Cap | $2.00B |
| Revenue YoY Growth | +0.4% |
| 52-Week Range | $10.33 – $27.68 |
| Shares Outstanding | 151.2 million (basic, 2026 Q2) |
Chemours Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $4.97B | $6.34B | $6.79B | $6.03B | $5.78B | $5.81B |
| Cost of Goods Sold | $3.90B | $4.96B | $5.18B | $4.72B | $4.63B | $4.91B |
| Gross Profit | $1.07B | $1.38B | $1.62B | $1.31B | $1.15B | $902.0M |
| Operating Income | $367.0M | $676.0M | $772.0M | -$245.0M | $341.0M | -$64.0M |
| Pre-Tax Income | $179.0M | $676.0M | $741.0M | -$318.0M | $127.0M | -$277.0M |
| Income Tax | -$40.0M | $68.0M | $163.0M | -$81.0M | $41.0M | $109.0M |
| Net Income | $219.0M | $608.0M | $578.0M | -$238.0M | $86.0M | -$386.0M |
| Diluted EPS | $1.32 | $3.60 | $3.65 | -$1.60 | $0.57 | -$2.57 |
Chemours Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.50B | $1.33B | $1.38B | $1.59B |
| Net Income | $60.0M | -$61.0M | -$29.0M | -$274.0M |
| Diluted EPS | $0.40 | -$0.41 | -$0.19 | -$1.81 |
Chemours Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.45B | $1.10B | $1.20B | $713.0M | $670.0M |
| Current Assets | $2.63B | $3.35B | $3.21B | $3.83B | $3.03B | $3.00B |
| Total Assets | $7.08B | $7.55B | $7.64B | $8.25B | $7.51B | $7.38B |
| Current Liabilities | $1.44B | $1.86B | $1.89B | $2.49B | $1.80B | $1.69B |
| Total Long-Term Debt | $4.00B | $3.72B | $3.59B | $3.99B | $4.05B | $4.10B |
| Total Liabilities | $6.27B | $6.47B | $6.53B | $7.51B | $6.91B | $7.13B |
| Shareholders' Equity | $813.0M | $1.08B | $1.11B | $737.0M | $604.0M | $250.0M |
Chemours Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $807.0M | $820.0M | $754.0M | $556.0M | -$633.0M | $264.0M |
| Cash From Investing | -$234.0M | $220.0M | -$284.0M | -$229.0M | -$353.0M | -$206.0M |
| Cash From Financing | -$449.0M | -$560.0M | -$685.0M | $172.0M | -$36.0M | -$126.0M |
| Free Cash Flow | $540.0M | $543.0M | $447.0M | $186.0M | -$993.0M | $51.0M |
Figures from Chemours' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Chemours financials page for every line item.
Chemours Company Profile
| Ticker | CC |
|---|---|
| Exchange | NYSE |
| Industry | Chemicals & Allied Products |
| Headquarters | Wilmington, Delaware |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001627223 |
Frequently Asked Questions
What was Chemours' revenue in fiscal 2025?
Chemours (CC) reported revenue of $5.81B for fiscal 2025.
What is Chemours' annual revenue history?
Chemours' annual revenue by fiscal year: 2020: $4.97B; 2021: $6.34B; 2022: $6.79B; 2023: $6.03B; 2024: $5.78B; 2025: $5.81B.
What was Chemours' net income in fiscal 2025?
Chemours reported net income of -$386.0M for fiscal 2025.
What was Chemours' earnings per share (EPS) in fiscal 2025?
Chemours' diluted EPS was -$2.57 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Chemours generate in fiscal 2025?
Chemours generated $51.0M of free cash flow in fiscal 2025.
What was Chemours' revenue last quarter?
In its most recent reported quarter (2026 Q2), Chemours reported revenue of $1.59B.
How much debt does Chemours have?
Chemours reported $4.10B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Chemours are outstanding?
Chemours reported a weighted average of 151.2 million basic shares outstanding in 2026 Q2.
What is Chemours' market cap?
Based on its latest closing price, Chemours (CC) has a market capitalization of about $2.00B.
When does Chemours' fiscal year end?
Chemours' fiscal year end, as registered with the SEC, is December 31.
Where is Chemours headquartered?
Chemours lists its business address in Wilmington, Delaware in its SEC filings.